NEWLEPTÏL
Active material: Peritsiazin
When ATH: N05AC01
CCF: Antipsychotic drug (anxiolytic)
When CSF: 02.01.01.01
Manufacturer: AVENTIS Laboratories (France)
Pharmaceutical form, composition and packaging
Capsules hard gelatin, opaque, and the housing lid white; contents of capsules – yellow powder, practically odorless.
1 caps. | |
peritsiazin | 10 mg |
Excipients: calcium hydrogen phosphate dihydrate, magnesium stearate.
10 PC. – blisters (5) – packs cardboard.
Oral solution 4% in the form of a transparent, fluorescent yellow-brown liquid with a smell of mint.
1 ml | |
peritsiazin | 40 mg |
Excipients: tartaric acid, vitamin C, a concentrated sugar syrup, glycerol (glycerol), ethanol 95%, essential oil of peppermint, caramel (E150), Purified water.
125 ml – vials of dark glass (1) complete with a plastic syringe doser – packs cardboard.
Pharmacological action
Pharmacological action – antipsychotic, antispasmodic, antiemetic, sedation, snotvornoe. Blocks dopaminergic receptors (mainly D2), adrenergic, serotonergic, m-cholinergic receptors.
Testimony
- psihopatii (excitable and hysterical type),
- psychopathic disorders of organic origin with a predominance of affect and behavior sthenic,
- psychopathic condition in schizophrenia (incl. geboidnye),
- paranoid state within the organic, vascular, presenile and senile diseases;
- epilepsy with affective-explosive characterological symptoms and dysphoric states.
Dosage regimen
Inside, at the beginning of treatment – 5-10 Mg (patients hypersensitive – 2-3 Mg) 3-4 Times daily, average daily dose – 30-40 Mg, maximum – 50-60 Mg.
Side effect
Oppression, dyskinesias: early (spasmodic torticollis, okulomotornыy crisis, Trizm) and late, extrapyramidal disorders; orthostatic hypotension, dry mouth, constipation, Parez akkomodacii, urinary retention, impotence, frigidity, amenorrhea, galactorrhea, gynecomastia, hyperprolactinemia, weight gain, hyperthermia, cholestatic jaundice, photosensitivity, agranulocytosis (rarely).
Contraindications
- toxic agranulocytosis history,
- zakrыtougolynaya glaucoma,
- porphyria,
- prostate adenoma.
Pregnancy and lactation
These are not represented.
Cautions
In the case of hyperthermia treatment should be stopped immediately.
Particularly careful monitoring is required in the treatment of epilepsy (in connection with a possible lowering epileptic threshold) and Parkinson's disease.
Carefully prescribed to elderly patients (sedation and hypotensive effects); cardiovascular diseases, kidney or liver failure; transport drivers and those, working with machinery (drowsiness and decreased, especially at the beginning of treatment, reaction).
Overdose
Data on overdose are not represented.
Drug Interactions
It enhances the effect of drugs, analgesics, ʙarʙituratov, alcohol, antihypertensives, trankvilizatorov.
Conditions and terms
Store at a temperature not exceeding 25 °C.
Shelf life – 5 years.